Lisata Therapeutics Inc (LSTA)

Jun 18, 2025

Strategic Collaboration with GATC Health Boosts Lisata Therapeutics’ Growth Potential - TipRanks

Jun 18, 2025

Jun 18, 2025

H.C. Wainwright maintains Lisata Therapeutics stock rating on AI partnership By Investing.com - Investing.com India

Jun 18, 2025

Jun 18, 2025

Lisata and GATC to use AI for new opioid use disorder drug - The Pharma Letter

Jun 18, 2025

Jun 18, 2025

Lisata collaborates with GATC Health on drug development - Yahoo Finance

Jun 18, 2025

Jun 17, 2025

Market movers: T-Mobile, Sunrun, First Solar, Lisata Therapeutics... - Proactive financial news

Jun 17, 2025

Jun 17, 2025

Lisata Therapeutics to lead development of opioid use disorder drug under expanded alliance - Proactive Investors

Jun 17, 2025

Jun 17, 2025

Lisata Therapeutics Advances Certepetide for Cancer Treatment - TipRanks

Jun 17, 2025

Jun 17, 2025

Lisata Therapeutics (LSTA) Partners with GATC Health to Boost Drug Development | LSTA Stock News - GuruFocus

Jun 17, 2025

Jun 17, 2025

Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development | LSTA Stock News - GuruFocus

Jun 17, 2025

Jun 17, 2025

Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development - GlobeNewswire

Jun 17, 2025

Jun 13, 2025

Lisata Therapeutics Amends Executive Employment Agreements - TipRanks

Jun 13, 2025

Jun 11, 2025

Lisata Therapeutics to Present at the 2025 BIO International Convention | LSTA Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

Lisata Therapeutics to Present at the 2025 BIO International Convention - The Manila Times

Jun 11, 2025

Jun 11, 2025

Lisata CEO to Reveal Latest Cancer Treatment Developments at Major Biotech Conference - Stock Titan

Jun 11, 2025

Jun 11, 2025

Lisata Therapeutics CEO to present at 2025 BIO International Convention - Proactive financial news

Jun 11, 2025

Jun 11, 2025

Citadel Advisors LLC Makes New $69,000 Investment in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World

Jun 11, 2025

Jun 10, 2025

Kalkine : Lisata Therapeutics Earnings Per Share Reflects Biotech Market Trends - Kalkine Media

Jun 10, 2025

Jun 10, 2025

Lisata Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 10, 2025

Jun 10, 2025

Lisata Therapeutics (NASDAQ:LSTA) Trading Down 2.2% – What’s Next? - Defense World

Jun 10, 2025

May 19, 2025

Dimensional Fund Advisors LP Increases Stock Position in Lisata Therapeutics, Inc. (NASDAQ:LSTA) - Defense World

May 19, 2025

May 12, 2025

Lisata outlines data-rich year ahead with multiple clinical milestones for Certepetide - MSN

May 12, 2025

May 10, 2025

Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 09, 2025

Lisata Therapeutics’ Earnings Call Highlights Progress - TipRanks

May 09, 2025

May 09, 2025

Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 09, 2025

May 09, 2025

Lisata Therapeutics Inc (LSTA) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Market ... - Yahoo Finance

May 09, 2025

May 09, 2025

Earnings call transcript: Lisata Therapeutics sees improved Q1 2025 performance - Investing.com

May 09, 2025

May 09, 2025

Lisata Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

Lisata eyes key trial milestones in 2025 as certepetide development gains momentum - Proactive financial news

May 08, 2025

May 06, 2025

Lisata Therapeutics Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

May 06, 2025

May 01, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 - The Manila Times

May 01, 2025

May 01, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial - GlobeNewswire

May 01, 2025

May 01, 2025

Lisata Therapeutics Earnings: Solid Tumor Treatment Developer Reports Q1 2025 Results May 8 - Stock Titan

May 01, 2025

Apr 26, 2025

Will Lisata Therapeutics (NASDAQ:LSTA) Spend Its Cash Wisely? - Yahoo Finance

Apr 26, 2025

Apr 24, 2025

LSTALisata Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 22, 2025

Lisata Therapeutics (NASDAQ:LSTA) Shares Up 0.9% – Still a Buy? - Defense World

Apr 22, 2025

Apr 20, 2025

Lisata Therapeutics talks ADC breakthrough with Catalent – ICYMI - Proactive financial news

Apr 20, 2025

Apr 17, 2025

Lisata Therapeutics announces research license with Catalent - MSN

Apr 17, 2025

Apr 16, 2025

Lisata Therapeutics CMO discusses potential for certepetide under Catalant license agreement - Proactive financial news

Apr 16, 2025

Apr 16, 2025

Lisata Therapeutics CMO discusses potential for certepetide under Catalent license agreement - Proactive Investors

Apr 16, 2025

Apr 15, 2025

Market movers: Meta, HPE, Applied Digital, Lisata Therapeutics... - Proactive Investors

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics (LSTA) Partners with Catalent on Preclinical Study | LSTA Stock News - GuruFocus

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics Announces Research License with Catalent - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Lisata Therapeutics, Inc. Announces Research License with Catalent, Inc - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Lisata falls after mid-stage data for anticancer agent - MSN

Apr 15, 2025

Apr 15, 2025

Lisata, Catalent partner for cancer drug research By Investing.com - Investing.com Canada

Apr 15, 2025

Apr 12, 2025

Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’ - marketscreener.com

Apr 12, 2025

Apr 05, 2025

Neostem stock plunges to 52-week low at $2.01 amid market challenges - Investing.com Australia

Apr 05, 2025

Apr 04, 2025

Neostem stock plunges to 52-week low at $2.01 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 21, 2025

Healthcare investment strategies reshaped by inflation, interest rates and M&A in 2025 - Proactive financial news

Mar 21, 2025

Mar 18, 2025

Endometriosis Pain Pipeline 2025: FDA Approvals and Clinical - openPR.com

Mar 18, 2025